Remote Evaluation of MIND Diet
Part of paid clinical trials in Urbana, Illinois.
- Sponsor
- University of Illinois at Urbana-Champaign
- Study ID
- NCT06450977
- Status
- Recruiting
Conditions
- Cognitive Change
- Multiple Sclerosis
- Nutrition, Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- MIND Diet — OTHERDaily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.
- Control Diet — OTHERDaily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.
Study Details
The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.
Key Dates
- Start date
- Jun 7, 2024
- Status verified
- Jun 2024
- Primary completion
- Jan 1, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: MIND DietParticipants in the active MIND diet group will be asked to consume one ready-to-eat meal per day from Daily Harvest® meal delivery service. The treatment meals will follow MIND diet guidelines and include leafy green vegetables, nuts, legumes, whole grains, berries, and extra virgin olive oil.
- Active Comparator: Control DietParticipants in the control diet group will be asked to consume one ready-to-eat meal per day from Daily Harvest® meal delivery service. The Control group will receive daily meals that are isocaloric with the active/experimental meals but will follow a general diet based on the average American diet and Dietary Guidelines for Americans (i.e., vegetables, fruits, nuts, whole grains, and unsaturated fats).
Primary Outcome Measure
Information Processing [ Time Frame: 12 weeks (Baseline vs. Follow Up) ]
Central Contacts
- Naiman Khan, PhD2173001667
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Urbana-Champaign | Urbana | Illinois | 61801 | Naiman Khan, PhD/RD |
Find similar trials in Urbana, IL
Related Studies
- Quality Improvement and Practice Based Research in Neurology Using the EMRPHASE4 · Enrolling By Invitation · Endeavor Health · Evanston, Illinois
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Exercise Training for Managing Major Depressive Disorder in Multiple SclerosisRecruiting · University of Illinois at Chicago · Chicago, Illinois
- An Individualized-health eLibrary App for People With Multiple SclerosisRecruiting · University of Illinois at Urbana-Champaign · Champaign, Illinois